ArticleTaiwan journal of ophthalmology

Patient-reported outcomes from a phase IV study of aflibercept in patients with refractory retinal vein occlusions.

Kimberly Spooner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.